Newsfeeds Archive - Spark Newswire

1 minute read

MicroStrategy Was The Best Among These 10 Large-Cap Stocks Scoring Big Last Week (May 12-May 19, 2024): Are They In Your Portfolio?

May 19, 7:27 PM

Top performing large-cap stocks in the last week: MSTR, MNDY, ONON, SE, PODD, DELL, VOD, ALC, SMCI, CRBG. Analysts raise price targets & more positive news.

AIG

1 minute read

Contact Lens Maker Alcon’s Has New Growth Avenues, Analyst Upgrades Stock

By Vandana Singh

May 15, 2:35 PM

Alcon's recent upgrades and promising opportunities, including the BELKIN Vision acquisition, expanding glaucoma treatment options, enhanced PanOptix IOL, and market advancements in China.

ALC

1 minute read

Alcon Analysts Increase Their Forecasts Following Q1 Results

By Avi Kapoor

May 15, 8:13 AM

Alcon Inc. (NYSE:ALC) posted mixed first-quarter financial results, after the closing bell on Monday. Alcon posted adjusted earnings…

ALC

4 minute read

Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

By Avi Kapoor

May 14, 1:30 PM

Shares of Alibaba Group Holding Limited (NYSE:BABA) fell sharply during Tuesday’s session following mixed first-quarter financial results. The…

AGYS

3 minute read

Sony Group Posts Upbeat Earnings, Joins GameStop, Paysafe And Other Big Stocks Moving Higher On Tuesday

By Avi Kapoor

May 14, 11:01 AM

U.S. stocks were higher, with the Dow Jones gaining around 20 points on Tuesday. Shares of Sony Group…

AGYS

2 minute read

Why Alcon Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket

By Avi Kapoor

May 14, 8:30 AM

Shares of Alcon Inc. (NYSE:ALC) rose sharply in today’s pre-market trading following better-than-expected first-quarter earnings. Alcon posted adjusted…

AKYA

2 minute read

Earnings Preview: What To Expect To When Eye Health Company Bausch + Lomb Reports Q4 Performance Later This Month

By Vandana Singh

February 9, 3:24 PM

"Bausch + Lomb's Q4 & FY 2023 results on Feb 21, 2024. Expecting $1.107 billion in sales, $0.17 EPS. RBC Capital predicts $1.159 billion revenue. Insights on Miebo launch and enhanced EBITDA margins for 2024.

ALC

1 minute read

Buy This Ophthalmology Stock But Sell This One, Says Bernstein Analyst: ‘Innovation Is Key’

By Priya Nigam

January 23, 1:47 PM

Innovation and digitalization have been in focus among ophthalmology majors.

ALC

1 minute read

Good News For Dry Eye Disease Patients: Eye Care Focused Alcon’s Treatment Shows Encouraging Benefit In Late-Stage Trials

By Vandana Singh

January 10, 7:53 AM

Alcon (NYSE: ALC) released topline results from the two Phase 3 trials (COMET-2 and COMET-3) evaluating the efficacy and safety of AR-15512, a candidate treatment for the signs and symptoms of

ALC